Lucid Diagnostics, Inc. (LUCD)
0.6273
-0.01
(-1.18%)
USD |
NASDAQ |
Oct 02, 16:00
0.6349
+0.01
(+1.21%)
After-Hours: 20:00
Lucid Diagnostics Price to Book Value : 10.95 for Oct. 2, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 02, 2026 | 10.95 |
| October 01, 2026 | 11.08 |
| September 30, 2026 | 13.11 |
| September 29, 2026 | 14.12 |
| September 28, 2026 | 14.07 |
| September 25, 2026 | 14.42 |
| September 24, 2026 | 14.63 |
| September 23, 2026 | 14.65 |
| September 22, 2026 | 15.58 |
| September 21, 2026 | 14.75 |
| September 18, 2026 | 13.72 |
| September 17, 2026 | 13.62 |
| September 16, 2026 | 14.60 |
| September 15, 2026 | 13.85 |
| September 14, 2026 | 13.66 |
| September 11, 2026 | 13.67 |
| September 10, 2026 | 14.04 |
| September 09, 2026 | 14.33 |
| September 08, 2026 | 15.66 |
| September 04, 2026 | 16.40 |
| September 03, 2026 | 16.61 |
| September 02, 2026 | 17.28 |
| September 01, 2026 | 17.01 |
| August 31, 2026 | 17.08 |
| August 28, 2026 | 17.31 |
| Date | Value |
|---|---|
| August 27, 2026 | 17.18 |
| August 26, 2026 | 16.95 |
| August 25, 2026 | 17.63 |
| August 24, 2026 | 17.46 |
| August 21, 2026 | 16.83 |
| August 20, 2026 | 16.77 |
| August 19, 2026 | 17.63 |
| August 18, 2026 | 17.27 |
| August 17, 2026 | 17.07 |
| August 14, 2026 | 16.89 |
| August 13, 2026 | 16.85 |
| August 12, 2026 | 17.19 |
| August 11, 2026 | 16.78 |
| August 10, 2026 | 16.78 |
| August 07, 2026 | 16.88 |
| August 06, 2026 | 16.64 |
| August 05, 2026 | 17.46 |
| August 04, 2026 | 16.75 |
| August 03, 2026 | 16.91 |
| July 31, 2026 | 15.22 |
| July 30, 2026 | 15.73 |
| July 29, 2026 | 16.04 |
| July 28, 2026 | 15.96 |
| July 27, 2026 | 15.77 |
| July 24, 2026 | 15.84 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| IDEXX Laboratories, Inc. | 25.36 |
| Neogen Corp. | 1.264 |
| QuidelOrtho Corp. | 0.4144 |
| Aspira Women's Health, Inc. | -- |
| VolitionRX Ltd. | -- |
Price to Book Value Related Metrics
| PS Ratio | 16.20 |
| Price | 0.6273 |
| Earnings Yield | -74.80% |
| Market Cap | 119.66M |